These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8983354)

  • 1. [Chronic myeloid leukemia. Karyotype changes].
    Rojas-Atencio A; Pineda-Del Villar L; Avila-León E; González-Ferrer S; Prieto-Carrasquero M; Soto M; González R
    Invest Clin; 1996 Sep; 37(3):167-75. PubMed ID: 8983354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of imatinib mesylate on patients with Philadelphia chromosome-positive chronic myeloid leukemia with secondary chromosomal aberrations.
    Mohamed AN; Pemberton P; Zonder J; Schiffer CA
    Clin Cancer Res; 2003 Apr; 9(4):1333-7. PubMed ID: 12684401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic study of chronic myeloid leukemia.
    Michalová K; Musilová J; Koudelová Z; Placerová J; Matuchová L
    Neoplasma; 1988; 35(5):571-81. PubMed ID: 3216931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of secondary chromosomal aberrations of chronic myelocytic leukemia.
    Wang Y; Hopwood VL; Hu P; Lennon A; Osterberger J; Glassman A
    Cancer Genet Cytogenet; 2004 Aug; 153(1):53-6. PubMed ID: 15325094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression.
    Bacher U; Haferlach T; Hiddemann W; Schnittger S; Kern W; Schoch C
    Cancer Genet Cytogenet; 2005 Feb; 157(1):53-61. PubMed ID: 15676148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic abnormalities in 532 patients with myeloid leukemias and myelodyplastic syndrome. The Czechoslovak MDS Cooperative Group.
    Michalová K; Musilová J; Zemanová Z
    Czech Med; 1990; 13(4):133-44. PubMed ID: 2081440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
    Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
    Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial cytogenetic studies in allografted patients with chronic myeloid leukemia.
    Bilhou-Nabera C; Bernard P; Marit G; Viard F; Gharbi MJ; Wen Z; Lacombe F; Broustet A; Reiffers J
    Bone Marrow Transplant; 1992 Apr; 9(4):263-8. PubMed ID: 1600414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
    Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
    Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chromosomal abnormalities in 38 CML cases of various phases].
    Su XY; Cao Q; He KL
    Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):34-7. PubMed ID: 11601004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytogenetic and molecular analysis of 1193 cases with chronic myeloid leukemia].
    Jiang DZ; Chen ZM; Lou JY; Wang YG; Liang Y; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):1-5. PubMed ID: 17649716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic significance of additional chromosomal abnormalities in Ph positive bone marrow cells in chronic myeloid leukemia].
    Lozyns'ka MP; Masliak ZV; Lukavets'kyĭ LM; Tsiapka OM; Lozyns'kyĭ RIu
    Tsitol Genet; 2005; 39(1):26-33. PubMed ID: 16018175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.
    Medina J; Kantarjian H; Talpaz M; O'Brien S; Garcia-Manero G; Giles F; Rios MB; Hayes K; Cortes J
    Cancer; 2003 Nov; 98(9):1905-11. PubMed ID: 14584073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicolor COBRA-FISH analysis of chronic myeloid leukemia reveals novel cryptic balanced translocations during disease progression.
    Barbouti A; Johansson B; Höglund M; Mauritzson N; Strömbeck B; Nilsson PG; Tanke HJ; Hagemeijer A; Mitelman F; Fioretos T
    Genes Chromosomes Cancer; 2002 Oct; 35(2):127-37. PubMed ID: 12203776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
    Pienkowska-Grela B; Woroniecka R; Solarska I; Kos K; Pastwińska A; Konopka L; Majewski M
    Cancer Genet Cytogenet; 2007 Apr; 174(2):111-5. PubMed ID: 17452251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution analysis of acquired genomic imbalances in bone marrow samples from chronic myeloid leukemia patients by use of multiple short DNA probes.
    Reid AG; Tarpey PS; Nacheva EP
    Genes Chromosomes Cancer; 2003 Jul; 37(3):282-90. PubMed ID: 12759926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.